Velan-Capital-Investment-Management-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
47
Total Value
90023167
Accession Number
0000938552-25-000003
Form Type
13F-HR
Manager Name
Velan-Capital-Investment-Management-Lp
Data Enrichment
94% identified
44 identified3 unidentified

Holdings

47 positions • $90.0M total value
Manager:
Search and click to pin securities to the top
Page 1 of 3
HERON THERAPEUTICS, INC. /DE/
Shares:7.0M
Value:$15.4M
% of Portfolio:17.1% ($15.4M/$90.0M)
ACELYRIN, Inc.
Shares:3.4M
Value:$8.3M
% of Portfolio:9.2% ($8.3M/$90.0M)
SpringWorks Therapeutics, Inc.
Shares:185.5K
Value:$8.2M
% of Portfolio:9.1% ($8.2M/$90.0M)
Protara Therapeutics, Inc.
Shares:1.7M
Value:$7.1M
% of Portfolio:7.9% ($7.1M/$90.0M)
Praxis Precision Medicines, Inc.
Shares:185.0K
Value:$7.0M
% of Portfolio:7.8% ($7.0M/$90.0M)
Verona Pharma plc
Shares:95.0K
Value:$6.0M
% of Portfolio:6.7% ($6.0M/$90.0M)
488445206
Shares:665.0K
Value:$5.0M
% of Portfolio:5.5% ($5.0M/$90.0M)
Tourmaline Bio, Inc.
Shares:319.1K
Value:$4.9M
% of Portfolio:5.4% ($4.9M/$90.0M)
Liquidia Corp
Shares:300.0K
Value:$4.4M
% of Portfolio:4.9% ($4.4M/$90.0M)
45779A846
Shares:904.0K
Value:$2.4M
% of Portfolio:2.7% ($2.4M/$90.0M)
scPharmaceuticals Inc.
Shares:917.7K
Value:$2.4M
% of Portfolio:2.7% ($2.4M/$90.0M)
Mineralys Therapeutics, Inc.
Shares:150.6K
Value:$2.4M
% of Portfolio:2.7% ($2.4M/$90.0M)
Replimune Group, Inc.
Shares:182.1K
Value:$1.8M
% of Portfolio:2.0% ($1.8M/$90.0M)
Edesa Biotech, Inc.
Shares:687.5K
Value:$1.7M
% of Portfolio:1.9% ($1.7M/$90.0M)
Instil Bio, Inc.
Shares:69.0K
Value:$1.2M
% of Portfolio:1.3% ($1.2M/$90.0M)
Rezolute, Inc.
Shares:400.0K
Value:$1.2M
% of Portfolio:1.3% ($1.2M/$90.0M)
Eledon Pharmaceuticals, Inc.
Shares:324.0K
Value:$1.1M
% of Portfolio:1.2% ($1.1M/$90.0M)
Perspective Therapeutics, Inc.
Shares:500.0K
Value:$1.1M
% of Portfolio:1.2% ($1.1M/$90.0M)
Jasper Therapeutics, Inc.
Shares:245.3K
Value:$1.1M
% of Portfolio:1.2% ($1.1M/$90.0M)
GERON CORP
Shares:655.0K
Value:$1.0M
% of Portfolio:1.2% ($1.0M/$90.0M)